Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biogaia AB
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Net Issuance of Common Stock
-kr417k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Net Issuance of Common Stock
kr990k
CAGR 3-Years
-47%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probi AB
STO:PROB
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Net Issuance of Common Stock
kr476m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
53%
BioArctic AB
STO:BIOA B
Net Issuance of Common Stock
kr15m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
112.88 SEK
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biogaia AB's Net Issuance of Common Stock?
Net Issuance of Common Stock
-417k SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Net Issuance of Common Stock amounts to -417k SEK.

What is Biogaia AB's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
-95%

Over the last year, the Net Issuance of Common Stock growth was -95%.

Back to Top